Generic Product News (January 2018)

JANUARY 29, 2018

CARVEDILOL PHOSPHATE
MARKETED BY:
Sun Pharmaceutical Industries Ltd
COMPARE TO: Coreg CR (GlaxoSmithKline)
INDICATION: The FDA has approved carvedilol phosphate, the generic version of Coreg CR. Carvedilol phosphate extended-releast tablets are indicated for the treatment of mild to severe chronic heart failure to increase survival and reduce hospitalization risk.
DOSAGE: Capsules: 10, 20, 40, and 80 mg
FOR MORE INFORMATION: sunpharma.com


NYSTATIN AND TRIAMCINOLONE ACETONIDE CREAM
MARKETED BY:
Perrigo
COMPARE TO: Mycolog II Cream (Apothecon)
INDICATION: Perrigo has launched nystatin and triamcinolone acetonide cream USP (100,000 units/g and 1 mg/g), an AB-rated generic version of Mycolog II Cream,which is indicated for the treatment of cutaneous candidiasis.
DOSAGE: Topical
FOR MORE INFORMATION: perrigo.com


HYDROMORPHONE HCL
MARKETED BY:
Perrigo
COMPARE TO: Exalgo (Mallinckrodt, Inc)
INDICATION: Perrigo has launched an AB-rated generic version of Exalgo (hydromorphone HCl) Extended-Release Tables (CII), which are indicated for the management of moderate to severe pain in opioid-tolerant patients requiring continuous opioid analgesia for an extended period of time.
DOSAGE: Tablets: 32 mg
FOR MORE INFORMATION: perrigo.com


HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS
MARKETED BY:
Lupin Pharmaceuticals
COMPARE TO: Norco (Allergan)
INDICATION: Lupin Pharmaceuticals has launched its hydrocodone bitartrate and acetaminophen tablets USP. Norco is indicated for the relief of moderate to moderately severe pain.
DOSAGE: Tablets: 5 mg/325 mg, 7.5 mg/325 mg, and 10 mg/325 mg
FOR MORE INFORMATION: lupinpharmaceuticals.com

SHARE THIS
0